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The endoplasmic reticulum (ER) is a key organelle regulating
intracellularCa2homeostasis.Oxidants andmitochondria-de-
rived free radicals can target ER-based Ca2 regulatory proteins
and cause uncontrolledCa2 release thatmay contribute to pro-
tracted ER stress and apoptosis. Several ER stress proteins have
been suggested to counteract the deregulation of ER Ca2
homeostasis and ER stress. Here we showed that knockdown of
Herp, an ubiquitin-like domain containing ER stress protein,
renders PC12 and MN9D cells vulnerable to 1-methyl-4-phe-
nylpyridinium-induced cytotoxic cell death by a mechanism
involving up-regulation of CHOP expression and ER Ca2
depletion. Conversely, Herp overexpression confers protection
by blocking 1-methyl-4-phenylpyridinium-induced CHOP up-
regulation, ER Ca2 store depletion, and mitochondrial Ca2
accumulation in amanner dependent on a functional ubiquitin-
proteasomal protein degradation pathway.Deletion of the ubiq-
uitin-like domain of Herp or treatment with a proteasomal
inhibitor abolished the central function of Herp in ER Ca2
homeostasis. Thus, elucidating the underlyingmolecularmech-
anism(s) whereby Herp counteracts Ca2 disturbances will pro-
vide insights into the molecular cascade of cell death in dopa-
minergic neurons andmay uncover novel therapeutic strategies
to prevent and ameliorate Parkinson disease progression.
Parkinson disease (PD)2 is the second most common age-
related neurodegenerative disorder that results in the selective
degeneration of dopaminergic neurons of the substantia nigra
pars compacta (1, 2). The proximate cause of selective degen-
eration of dopaminergic neurons in PD has not been clearly
elucidated. Severalmechanisms are inferred to play a role in the
pathogenesis of PD based on studies from animals or in vitro
studies using dopaminergic neurotoxins. These include mito-
chondrial dysfunction, oxidative stress, and impairment of the
ubiquitin-proteasomal pathway (UPP) (1–3). It has been shown
that several genes that are mutated in familial PD encode for
proteins that have functions linked to UPP and mitochondria
(1–3). The UPP plays a critical role in ER-associated protein
degradation (ERAD), a protein quality control system of the ER
that eliminates misfolded proteins in the ER lumen (4). UPP
dysfunction results in the accumulation of misfolded or
unfolded proteins within the ER, which induces ER stress (5).
Important roles for ER stress and ER stress-induced cell
death have been reported in a broad spectrum of pathological
conditions (6). To alleviate ER stress and enhances cell survival,
cells launch the unfolded protein response (UPR), an adaptive
response to minimize accumulation of misfolded proteins that
would otherwise be toxic to the cell (7). The biological objec-
tives of the UPR are to reduce the overall protein translation,
increase the production of ER localized chaperones, and
increase the clearance of unfolded proteins by UPP (7).
Although short time UPR activation serves to reduce the
unfolded protein load, a protracted activation of UPR, as the
result of either severe or prolonged ER dysfunction, activates
the cell death program (7). Important mediators of ER stress-
associated death include the activation of the ER-associated
procaspase-12 (in mouse) or procaspase-4 (in human) and
increased expression of the pro-apoptotic transcription factor
CCAAT enhancer-binding protein homologous protein
(CHOP, also termed as growth arrest-DNA damage response
protein or Gadd153) (8).
Recent studies have demonstrated hallmarks of ER stress in
several experimentalmodels of PD (9–12) and in dopaminergic
neurons in the substantia nigra of PD subjects (13). Although
these studies indicate that ER stress is closely associated with
PD, it is yet not clear whether and how ER stress contributes to
the degenerative cascades in PD. Cells that fail to respond to ER
stress are more sensitive to neurotoxin-induced death (9), sug-
gesting that up-regulation of ER stress proteins, at least during
the early phase of the ER stress response, is important to restore
ER homeostasis and to prevent activation of the ER stress-in-
duced apoptotic program. Consistent with this notion, precon-
* This work was supported by funds from the American Federation on Aging
Research (to S. L. C.).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1–S5.
1 To whom correspondence should be addressed: Burnett School of Biomed-
ical Sciences, College of Medicine University of Central Florida, 4000 Cen-
tral Florida Blvd., Orlando, FL 32816. Tel.: 407-823-3584; Fax: 407-823-0956;
E-mail: schan@mail.ucf.edu.
2 The abbreviations used are: PD, Parkinson disease; ER, endoplasmic reticu-
lum; MPP, 1-methyl-4-phenylpyridinium; UPP, ubiquitin-proteasomal
pathway; ERAD, ER-associatedprotein degradation; UPR, unfoldedprotein
response; CHOP, CCAAT enhancer-binding protein homologous protein;
siRNA, small interfering RNA; RT, reverse transcription; ERK, extracellular
signal-regulated kinase; ANOVA, analysis of variance; UBL, ubiquitin-like;
ROS, reactive oxygen species.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 284, NO. 27, pp. 18323–18333, July 3, 2009
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
JULY 3, 2009•VOLUME 284•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 18323
 at U
CF H
ealth Sciences Library on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ditioning with a sublethal level of ER stress has been shown to
protect cells, in part through up-regulation of ER stress pro-
teins. Hence, understanding the molecular mechanisms by
which ER stress proteins overcome ER stress may help to
uncover novel approaches to block the ER stress-associated
pathological processes in cell culture and animal models of PD
(9–12).
Herp (homocysteine-inducible ER stress protein) is a mem-
brane-bound, ubiquitin-like protein that is located in the ER
(14). Herp expression is strongly up-regulated in cultured pri-
mary neurons exposed to proteasomal inhibitors or pharmaco-
logical agents that selectively induce ER dysfunction (14–16).
We previously reported that overexpression of Herp promotes
neuronal survival, whereas knockdown of Herp protein by
small interference RNA enhances vulnerability to ER stress-
and amyloid -peptide-induced apoptosis (16). The ability of
Herp to prevent ER stress-induced deathwas correlatedwith its
ability to stabilize cellular Ca2 homeostasis (16, 17). Here, we
investigated the role of Herp in the cellular response to 1-meth-
yl-4-phenylpyridinium (MPP), a neuro-toxicant commonly
used to elicit experimental models of PD (18). Because distur-
bances in intracellular Ca2 homeostasis have been implicated
in oxidative cell injury (19), we test the hypothesis of whether
Herp may play a role in counteracting MPP-induced distur-
bances in intracellular Ca2 homeostasis. Our results indicate
that knockdown of Herp increases MPP-induced CHOP
expression, ER Ca2 leakage, and vulnerability to MPP-in-
duced cytotoxic cell death, suggesting that Herp is critical for
survival adaptation to this PD neurotoxin.
EXPERIMENTAL PROCEDURES
Materials—1-Methyl-4-phenylpyridinium (MPP) and tu-
nicamycin were purchased from Sigma. Lactacystin and LLVY-
amino-4-methylcoumarin were obtained from BioMol. The
antibodies forHerp andCHOPwere obtained fromBioMol and
Santa Cruz Biotechnology. The antibody for ERK1 was
obtained from Cell Signaling. The antibodies to Grp78 and
Bcl-2 were purchased from Stressgen and Millipore, respec-
tively. Secondary antibodies conjugated to horseradish peroxi-
dase were from Jackson Immunoresearch, respectively. 7-
Dichloro-dihydrofluorescein diacetate was obtained from
Molecular Probes.
Generation of DNA Constructs—Plasmids containing the
full-length or mutant deletion human Herp cDNA were con-
structed as described previously (16). Site-directed mutagene-
sis was performed to generate by a PCR-based primer overlap
extension method. In brief, the same pair of flanking primers
and two different mutant overlapping primers were synthe-
sized as described (16). The PCR products that contained the
mutant sequence were subcloned into the PCR4 TOPO TA
cloning vector (Stratagene), which was then amplified and
digested with BamHI and EcoRII and subcloned into the
pcDNA3.1 vector. The mutation was confirmed by automated
DNA sequencing.
Generation of Stably Transfected Cell Lines—Transfection of
PC12 cells was carried out using the Lipofectamine reagent
(Invitrogen) as previously described (16). Stably expressing
clones were obtained after selection for growth in the presence
of geneticin (500 mg/liter) and characterized for Herp expres-
sion by immunoblot analysis. For experiments, PC12 cells were
plated onto glass coverslips and used between 18 and 48 h after
plating. Cells stably transfected with the empty vector were
used as controls.
Experimental Treatments—PC12 and MN9D cells were
treated with MPP (1 mM), tunicamycin (5 g/ml), and lacta-
cystin (5 M) in OPTI-MEM (Invitrogen). Each of these com-
pounds was prepared in Me2SO immediately before applying
them to the cultures. When Me2SO was used as the solvent,
their final concentration did not exceed 0.1%.At the end of each
treatment, the cultures were processed for immunoblotting
and for evaluating the extent of cell death.
RNA Interference—Herp and CHOP siRNA duplexes are
designed to specifically target the 21-nucleotide region 5-CGC-
AACAAATAGTCGGAACATC-3 of the Herp gene (NM_
004562.1) and 5-CTCTTGACCCTGCATCCCTA-3 of the
CHOP gene (nucleotides 270–291; NM_024134). These target
sequences were chosen based on previous experiments testing
the gene-silencing effectiveness of three to four siRNA
duplexes (16, 20). Blast searches confirmed that these
sequences were not homologous to any genes. A previously
described scrambled sequence (20) is used as siRNA-Control.
The cells were transfectedwith the siRNAduplexes using Lipo-
fectamine 2000 (Invitrogen) in Opti-MEM according to manu-
facturer’s protocol. After overnight incubation, the cultures
were washed and replaced with 2 ml of fresh serum containing
Dulbecco’s modified Eagle’s medium to allow recovery for 24 h.
Tomonitor knockdown, the cells were harvested and processed
for RT-PCR and/or Western blot analyses.
Quantification of Cell Survival—Cell viability was assessed
by the trypan blue exclusion method and the lactate dehydro-
genase release assay as described previously (16, 20). Cell via-
bility was evaluated in triplicates for each treatment. All of the
experiments were repeated at least three times.
RNA Isolation and RT-PCR—Total RNA from cells grown on
100-mm dishes was isolated with TRIzol (Invitrogen), and 2g
of RNA was reverse transcribed with Superscript II reverse
transcriptase and an oligo(dT) primer (Invitrogen). Semi-quan-
titative RT-PCR analyses of Herp, CHOP, and glyceraldehyde-3-
phosphate dehydrogenase were performed using the following
pairs of primers: rat Herp, 5-CCACTACCACAACTACCA-
CTG-3 (forward) and 5-CCTCTCTTTGGCTTTCTGGAA-3
(reverse); rat glyceraldehyde-3-phosphate dehydrogenase, 5-
TGTGATGGACTCCGGTGACGG-3 (forward) and 5-ACA-
GCTTCTCTTTGATGTCACGC-3 (reverse); rat CHOP, 5-
AAGGTCTACGAAGGTGAACGACCCC-3 (forward) and
5-GACCCCAAGACACGTGAGCAACTGC-3 (reverse); rat
Grp78/Bip, 5-CCACAAGGATGCAGACATTG-3 (forward)
and 5-AGGGCCTCCACTTCCATAGA-3 (reverse); and rat
glyceraldehyde-3-phosphate dehydrogenase (which served as
an internal control), 5-CCACAAGGATGCAGACATTG-3
(forward) and 5-AGGGCCTCCACTTCCATAGA-3 (reverse).
Measurement of ER andMitochondrial Ca2Concentrations—
FreeCa2 levels in the ER ([Ca2]ER) will be evaluated using the
ER-targeted YC4 (YC4-ER; gift of Dr. W. F. Graier, University
of Graz), a low affinity ratiometric “cameleon” indicator with a
KDEL sequence and a calreticulin signal peptide, as previously
Herp Inhibits MPP-induced Toxicity
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described (21). For measurement of mitochondria Ca2 level
([Ca2]M), the mitochondria-targeted ratiometric-pericam
(RP-mt; gift of Dr. A.Miyawaki, RIKENBrain Science Institute)
was used as described previously (22). Briefly, cells plated at
60% confluency on glass coverslips were transiently transfected
with 2 g of p-BudCR4.1-YC4-ER or pcDNA3-Rp-mt using
Lipofectamine. Twenty-four hours after transfection, the cells
were incubated with MPP, and changes in [Ca2]ER and
[Ca2]M were monitored by confocal laser scanning imaging
systemwith excitation set at 440 nm (for YC4-ER) or at 433 and
485 nm (for Rp-mt). Emission was monitored at 485 and 535
nm (for YC4-ER) or at 539 nm (for Rp-mt).Measurementswere
performed in Locke’s buffer containing: 154 mM NaCl, 5.6 mM
KCl, 2.3 mM CaCl2, 1.0 mM MgCl2, 3.6 mM NaHCO3, 5 mM
HEPES, and 10 mM D-glucose, pH 7.2 (16, 20). The data were
expressed as the ratios of the fluorescence in treated relative to
untreated cultures.
Protein Extraction, Immunoprecipitation, and Western
Blotting—Cell lysates for Western blotting were prepared in
T-PER lysis buffer (Pierce). In all of the experiments, the same
amount of total protein was loaded for each sample. The mem-
branes were probed with the primary antibodies: Herp, Grp78/
Bip, CHOP, and ERK1, followed by peroxidase-conjugated sec-
ondary antibody and developed with the Super Signal West
Pico Chemiluminescent substrate (Pierce). For immunopre-
cipitation, aliquots of cell lysates containing 300 g of protein
were incubated with rabbit polyclonal Herp antibody in immu-
noprecipitation buffer (150mMNaCl, 2mMEDTA, 1%Nonidet
P-40, 5 g/ml leupeptin, 5 g/ml aprotinin, 2 g/ml pepstatin
A, 0.25mMphenylmethylsulfonyl fluoride, 50mMTris, pH 7.6).
Antigen-antibody complexes were precipitated with immobi-
lized protein A, washed three times in immunoprecipitation
buffer, and solubilized by heating in Laemmli buffer containing
2-mercaptoethanol at 100 °C for 4 min. The solubilized pro-
teins were separated by SDS-polyacrylamide gel and then
immunoblotted with a polyclonal antibody to Bcl-2.
Proteasomal Activity—Chymotrypsin-like activity of protea-
some was assayed using the fluorogenic peptide Suc-Leu-Leu-
Val-Tyr-7-amino-4-methylcoumarin according to the method
reported previously (15). Briefly, after the treatment with
MG132 or lactacystin for 30min, cultures were harvested, lysed
in proteasome buffer (10mmol/liter Tris-HCl, pH 7.5, 1mmol/
liter EDTA, 2 mmol/liter adenosine-5-triphosphate, 20% glyc-
erol, and 4 mmol/liter dithiothreitol), and centrifuged at
13,000  g at 4 °C for 10 min. The supernatant (20 g of pro-
tein) was then incubated with proteasome activity assay buffer
(0.05 mol/liter Tris-HCl, pH 8.0, 0.5 mmol/liter EDTA, 40
mol/liter LLVY-amino-4-methylcoumarin) for 1 h at 37 °C.
The reaction was stopped by adding 0.9 ml of cold water and
placing the reaction mixture on ice for at least 10 min. Subse-
quently, the fluorescence of the solution was measured with a
fluorescence microplate reader with excitation at 380 nm and
emission at 440 nm. All of the readings were standardized rel-
ative to the fluorescence intensity of an equal volume of free
7-amino-4-methylcoumarin solution.
Statistical Analysis—Comparison between two groups was
performed using Student’s t test, whereas multiple compari-
sons between more than two groups was analyzed by one-way
ANOVAandpost hoc tests. The data evaluated for the effects of
two variables were analyzed using two-way ANOVA. The
results are presented as themeans standard deviation. For all
analyses, statistical significance is defined as p value of0.05.
RESULTS
Herp Is Required for Survival Adaptation to MPP-induced
ER Stress—Several ER stress inducible proteins such as Grp78
and Herp are constitutively expressed. To address the role of
Herp in the MPP-induced cell death model, we used RNA
interference to knockdown endogenous Herp expression.
Transfection of PC12 cells with a siRNA that targets Herp
(siRNA-Herp) resulted in a substantial reduction in the level
Herp protein (Fig. 1A). To evaluate the effect of Herp knock-
down on neuronal vulnerability to MPP toxicity, we assessed
cell viability by using the trypan blue exclusion (Fig. 1B) and
lactate dehydrogenase release (not shown). Exposure of cul-
tures to 0.5mMMPP induced45–50%cell deathwithin 24h.
Depletion ofHerp proteinmarkedly enhanced the vulnerability
of PC12 cells to MPP toxicity. Compared with cultures trans-
fected with a scramble control siRNA (siRNA-Con), there were
significantly more dead cells in cultures treated with siRNA-
Herp, indicating that down-regulation of Herp sensitizes PC12
cells to MPP-induced death (Fig. 1B). Similar results were
obtained inMN9D, amidbrain-derived dopaminergic neuronal
cell line (Fig. 1B). Next, we determined whether PC12 cells sta-
bly overexpressing Herp (PC12-Herp) are resistant to MPP-
induced death. Herp protein overexpression was confirmed in
three independent clones by immunoblotting (Fig. 1C). Com-
pared with PC12-VT, PC12-Herp cells were significantly more
resistant to 0.5 mM MPP (Fig. 1D), a dose that yielded 50%
cell death 24 h post-treatment (Fig. 1B). Collectively, the results
indicate that survival adaptation to MPP is dependent on
Herp function.
Given that Herp expression is responsive to ER stress (14–
16) and that ER stress has been shown to accompany neurotox-
in-induced death (9–11), we next evaluated whether MPP
may induce the expression of Herp. Levels of Herp mRNA and
protein in PC12 cells were not markedly increased after expo-
sure to MPP (Fig. 2A). The same dose of MPP also failed to
robustly increase Herp protein expression in MN9D cells (Fig.
2B), thus excluding the possibility that the observed anomaly in
Herp induction was cell type-specific. By contrast, the protein
level of Grp78, a marker of ER stress, was transiently up-regu-
lated in PC12 and MN9D cells by MPP (Fig. 2, A and B),
indicating activation of the ER stress response by MPP. For
comparison, we treated sister cultures with tunicamycin, a
known pharmacological ER stressor that causes protein accu-
mulation in the ERby inhibiting protein glycosylation (16). Lev-
els of both Herp and Grp78 protein were robustly up-regulated
in both PC12 andMN9Dcells after treatmentwith tunicamycin
(Fig. 2C). Taken together, the above results suggest that cells are
unable to induceHerp protein expression in response toMPP.
Herp Counteracts MPP-induced Perturbation of ER Ca2
Homeostasis—Oxidative stress is an important factor impli-
cated in the disruption of neuronal Ca2 homeostasis (23).
Consistent with previous reports (24, 25), MPP increased the
intracellular accumulation of hydroxyl and peroxynitrite in
Herp Inhibits MPP-induced Toxicity
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PC12 and MN9D cells (supplemental Fig. S1). Given that per-
turbations of intracellular Ca2 homeostasis have been impli-
cated in oxidative stress-induced cell death (19), we next exam-
ined the effects of MPP on ER Ca2 handling. To this end, we
monitor changes in the Ca2 concentration in the ER lumen
([Ca2]ER) of PC12 and MND9D cells at various time points
after treatment with MPP. The early rise in [Ca2]ER was
quickly followed by a gradual and progressive decline inMPP-
treated cells (Fig. 3A), suggesting that MPP increased Ca2
leakage from the ER.
Because Herp functions to stabilize ER Ca2 homeostasis
during ER stress (16, 17), we next evaluated whether overex-
pression of Herp prevents MPP-induced perturbations of
[Ca2]ER. Compared with PC12-VT cells, PC12-Herp cells
exhibited reduced ER Ca2 leakage and were able to maintain
[Ca2]ER (Fig. 3B). Because uncontrolled ER Ca2 release can
lead to protracted rise in the Ca2 concentration of the mito-
chondria ([Ca2]M) (8, 29) and because aberrantmitochondrial
Ca2 handling has been shown to be involved in MPP-in-
duced toxicity (30, 31), we next assessed changes in [Ca2]M in
PC12 and MN9D cells at various time points after treatment
with MPP. The decrease of [Ca2]ER was accompanied by an
increase in [Ca2]M inMPP-treated cells (Fig. 3C), indicating
that MPP induces Ca2 mobilization from the ER to mito-
chondria. As expected, the magnitude of the increase in
[Ca2]M was significantly attenuated in PC12-Herp (Fig. 3D),
suggesting thatHerp likely inhibits the toxicCa2 transfer from
the ER to mitochondria under oxi-
dant-induced ER stress. Represent-
ative pseudocolored images of the
indicated PC12 clones expressing
the fluorescent Ca2 indicators,
YC4-ER and pericam-mt, are shown
in Fig. 3 (B andD), respectively. Co-
localization studies confirmed that
the indicated fluorescent indicators
are properly targeted and expressed
either in the ER (YC4-ER) or in the
mitochondria (pericam-mt) (sup-
plemental Fig. S3).
Herp Blocks MPP-induced Acti-
vation of CHOP—CHOP has been
implicated as a mediator of apopto-
sis in the context of ER and oxida-
tive stress (32, 33). ER stress-in-
duced cell death in cultures occurs
only when CHOP is permanently
up-regulated but not when the
increase in CHOP is transient, sug-
gesting that CHOP contributes to
the activation of ER-initiated apo-
ptosis signaling (31–34). Given that
store depletion has been associated
with CHOP up-regulation (20, 35)
and that overexpression of Herp
counteracts MPP-induced ER
Ca2 store depletion (Fig. 3B), we
next evaluate whether CHOP is dif-
ferentially induced by MPP in PC12-VT and PC12-Herp
clones. Themagnitude of theMPP induced increase in CHOP
protein level was significantly lower in PC12-Herp when com-
pared with PC12-VT (Fig. 4A). The Herp-mediated suppres-
sion of CHOP was also associated with reduced Grp78 induc-
tion (Fig. 4A), suggesting that Herp restores ER homeostasis in
MPP-treated cells by inhibiting downstream events caused by
CHOP.
By contrast, suppression of endogenous Herp by RNA inter-
ference potentiates CHOP induction in MPP-treated PC12
cells (Fig. 4B). Treatment with siRNA-Con, which had no effect
on Herp expression (Fig. 1A), did not enhance MPP-induced
CHOP up-regulation (Fig. 4B). These data are consistent with a
previous study showing that Herp null cells displayed aberrant
ER stress signaling with increased level of CHOP transcript
when compared with wild-type control cells (15).
Next, we determined whether suppression of CHOP induc-
tion by RNA interference is sufficient to inhibit MPP toxicity.
siRNA targeting CHOP (siRNA-CHOP) (20) was used to
inhibit theMPP-inducedCHOPexpression in PC12 cells (Fig.
4C). Cell viability assessed by trypan blue exclusion assay
showed that siRNA-induced silencing of CHOP provided sig-
nificant protection against MPP toxicity (Fig. 4D). By con-
trast, the siRNA-Con did not rescue PC12 cells from MPP
toxicity (Fig. 4D). Interestingly, knockdown of CHOP did not
further rescue PC12-Herp cells from MPP-induced toxicity
(supplemental Fig. S2), suggesting that Herp promotes cell sur-
FIGURE 1.Herp protects fromMPP toxicity. A, PC12 cells were transfectedwith siRNA targeting Herp (Herp;
100 nM) or nonsilencing control siRNA (Con; 100 nM) for 24 and 48 h. For sequences of each siRNA-Herp or
siRNA-Con, see “Experimental Procedures.” Total protein lysates were prepared and analyzed by immunoblot-
ting using an anti-Herp antibody. Equal protein loading was confirmed by reprobing immunoblots with an
anti-ERK1 antibody. B, PC12 cells and MN9Dwere transfected with siRNA-Herp or siRNA-Con (100 nM) for 24 h
prior to exposure to 0.5 mM MPP or vehicle. At the indicated time points, the percentage of trypan blue-
positive cells in each culture was quantified. The values are the means and S.D. of three independent experi-
ments. *, p 0.01; #, p 0.05 (ANOVA with Scheffe post-hoc tests) compared with vehicle-treated cultures.
C, PC12 clones were stably transfected with plasmid containing Herp (Herp) or the empty plasmid (VT). Total
protein lysates were analyzed in three independent clones by Western blotting using an anti-Herp antibody.
Equal protein loadingwas confirmedby reprobing the immunoblotswith an anti-ERK1 antibody.D, cultures of
PC12-VT and PC12-Herp were left untreated or treated for the indicated time points with 0.5 mM MPP or
vehicle, and cell viability was assessed. The results were expressed as percentages of trypan blue-positive cells
in each culture, normalized to untreated cultures. The values represent themeans S.D. of three independent
experiments. *, p 0.01 (ANOVA with Scheffe post-hoc tests).
Herp Inhibits MPP-induced Toxicity
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vival in large by suppressing CHOP-dependent pro-apoptotic
signaling. Collectively, the above results indicate that Herp
attenuates MPP-induced cell death by inhibiting CHOP
up-regulation.
CHOP Contributes to MPP-induced Perturbation of ER
Ca2 Homeostasis—To determine whether CHOP up-regula-
tion in MPP-treated cells is causally linked to ER Ca2 store
depletion, we measured theMPP-induced perturbation in ER
Ca2 homeostasis in PC12 cells transfected with siRNA-
CHOP. Compared with siRNA-Control, siRNA-CHOP sub-
stantially reduced ER Ca2 leakage in MPP-treated PC12
cells. CHOP knockdown also attenuates MPP-induced ER
Ca2 store depletion (Fig. 5A). Because Herp suppressed
CHOP induction in MPP-treated PC12 cells, we examined
whether knockdown of Herp expression exacerbated MPP-
induced ER Ca2 store depletion. As expected, knockdown of
Herp exacerbated ER Ca2 leakage (Fig. 5B) in MPP-treated
PC12 cells (Fig. 5C). These data indicate that Herp prevents
CHOP-mediated ER Ca2 store depletion in MPP-treated
PC12 cells.
The Herp-dependent Protective Mechanism Is Not Mediated
by the Anti-apoptotic Bcl-2 Protein—Because CHOP has been
shown to down-regulate the expression of Bcl-2 protein (36)
and because overexpression of Bcl-2 affects Ca2 handling by
the ER (8, 37), we next determined whether Bcl-2 protein may
be acting downstream of Herp to maintain ER Ca2 homeosta-
sis in MPP-treated PC12 cells. Levels of Bcl-2 protein in
PC12-VT and PC12-Herp were not significantly different
before and after exposure to MPP (supplemental Fig. S4). To
rule out the possibility that Herp might interact with Bcl-2 and
therefore facilitated Bcl-2 association with the ER membrane,
we measured the amounts of Bcl-2 protein in isolated micro-
somes. Levels of Bcl-2 protein in the microsomes prepared
from PC12-Herp were comparable with those from PC12-VT
FIGURE 2.MPP and tunicamycin induce Herp and CHOP expressionwith different kinetics. PC12 (A) andMN9D (B) cells were treatedwith 0.5mMMPP
for the indicated time points. Total RNA and cell lysates were prepared and analyzed by semi-quantitative RT-PCR and immunoblotting for Herp and Grp78,
respectively. As control (Ctrl) for equal loading, actin mRNA and ERK1 protein were determined. Densitometric analyses of protein bands are shown next to
each panel. *, p 0.01 (ANOVA with Scheffe post-hoc tests) compared with untreated cultures. Asterisks indicated the full-length Herp protein. C, PC12 and
MN9D cells were treated with 5 g/ml tunicamycin for the indicated time points. Total lysates were prepared and analyzed by semi-quantitative RT-PCR and
immunoblotting for Herp and Grp78, respectively. Quantitation of the density of the protein bands is shown next to each panel. *, p  0.01 (ANOVA with
Scheffe post-hoc tests) compared with untreated cells.
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and were nearly unchanged following exposure to MPP (sup-
plemental Fig. S4). No interaction between Bcl-2 and Herp was
detected by co-immunoprecipitation analysis (supplemental
Fig. S4). All in all, although Herp affects Ca2 handling by the
ER in a manner resembling the effects of Bcl-2 overexpression,
data from these experiments excluded a role for Bcl-2 in the
Herp-dependent stabilization of ER Ca2 homeostasis in
MPP-treated cells.
The Ubiquitin-like (UBL) Domain Is Essential for Herp-me-
diated ER Ca2 Stabilization and Protection from MPP-in-
duced Toxicity—Previous studies established a critical role of
the N-terminal UBL domain in the cytoprotective action of
Herp (15–17). Overexpression of a mutant Herp deletion con-
struct lacking the UBL domain (UBL-Herp; Fig. 6A) failed to
protect PC12 cells from ER stress-induced cell death (15–17).
To determine whether the Herp-dependent protection against
MPP toxicity may also require the UBL domain, we generated
PC12 clones stably overexpressing UBL-Herp. Stable trans-
fection inducing overexpression of UBL-Herp was verified by
immunoblotting (Fig. 6A). Compared with PC12-VT, PC12-
UBL-Herp clones were not more resistant to MPP-induced
cell death (Fig. 6B), suggesting that the UBL domain is required
for Herp-dependent cytoprotective action.
To determine whether the UBL domain is essential for the
stabilization of ERCa2 homeostasis, wemeasured [Ca2]ER in
PC12-UBL-Herp. The magnitude of the MPP-induced ER
Ca2 leakage was indistinguishable in PC12-VT and PC12-
UBL-Herp, suggesting that the UBL domain is required for
the ability of Herp to maintain ER Ca2 homeostasis (Fig. 6C).
We also found that CHOP mRNA and protein levels in
PC12-VT clones are not significantly different in PC12-UBL-
Herp clones (Fig. 6D), which further supports the notion that a
functional Herp protein is required to suppress CHOP induc-
tion and to stabilize ER Ca2 homeostasis.
Herp-dependent Stabilization of ER Ca2 Homeostasis
Requires a FunctionalUPP—Herp has recently been implicated
in the regulation of ERAD (38, 39), a protein quality control
system of the ER, which eliminates misfolded proteins by UPP-
dependent degradation (4). To determine whether ERAD is
involved in the Herp-dependent stabilization of ER Ca2
homeostasis, we blocked ERADwith the proteasomal inhibitor
lactacystin. Treatment of PC12 cells with lactacystin for 12 and
FIGURE 3.Herp counteractsMPP-induced depletion of ER Ca2 store. Statistical evaluations of the changes in the Ca2 concentration in the ER ([Ca2]ER)
(A and B) andmitochondria ([Ca2]M) (C andD) in PC12 andMN9D cells (A and C) and in the indicated stably transfected PC12 clones (B andD) after treatment
with MPP. The indicated cultures were transiently transfected with 2 g of YC4-ER or RP-mt for 24 h prior to incubation with 0.5 mM MPP. At the indicated
time points, [Ca2]ER and [Ca
2]M were measured as described under “Experimental Procedures.” The results were expressed as the ratios of the YC4-ER or
RP-mt fluorescence signals in MPP-treated relative to untreated cultures. The values are themeans and S.D. of measurements made in three or four cultures
(n  4 dishes, 4–6 microscopic fields/dish, 25–30 cells/field). *, p  0.01; #, p  0.05 (ANOVA with Scheffe post-hoc tests) compared with either untreated
cultures or PC12-VT cultures. Representative pseudocolored images of the indicated PC12 clones at base line and after exposure to MPP are shown in B and
D. The pseudocolor bar shows the ratio range. Con, control.
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24 h significantly reduced proteasomal activity (supplemental
Fig. S5). Inhibition of proteasome function reversed the Herp-
dependent suppression of CHOP induction (Fig. 7A) and accel-
erates ERCa2 depletion (Fig. 7B), suggesting that proteosomal
activity is required for Herp-dependent stabilization of ER
Ca2 homeostasis. Consistent with the notion that the protea-
somal function is required for the neuroprotective action of
Herp, we found that lactacystin not only increased the vulner-
ability of PC12 cells (Fig. 7C) but also restores the sensitivity of
PC12-Herp clones to MPP toxicity (Fig. 7D).
DISCUSSION
Elucidating the specific and sequential molecular events
induced by MPP will provide a better understanding of the
molecular basis of dopaminergic cell death.MPP is selectively
toxic to dopaminergic neurons and has been studied exten-
sively as an etiologic model of PD because mitochondrial dys-
function is implicated in bothMPP toxicity and the pathogen-
esis of PD.MPP toxicity has been attributed to the generation
of reactive oxygen species (ROS) (24, 25). ROS generated from
mitochondrial appear to be a main contributor of oxidative
stress-mediated neurodegeneration in PD models (40).
Oxidative stress is an important factor implicated in the dis-
ruption of neuronal Ca2 homeostasis (19). In this study we
showed thatMPP induces the deregulation of ERCa2 home-
ostasis. There is a growing body of evidence that the ER can play
pivotal roles in regulating cell survival and apoptosis in a variety
of cell types including neurons. The ER servesmany specialized
functions in the cells including the biosynthesis of membrane
and secretory proteins (7) and maintenance of neuronal Ca2
FIGURE 4. Herp counteracts MPP-induced up-regulation of CHOP. A, time course of CHOP and Grp78 protein levels in cultures of PC12-VT and
PC12-Herp before and after incubation with 0.5 mM MPP. As control for equal loading, immunoblots were reprobed with an antibody to ERK1.
Densitometric analysis of protein bands normalized to untreated control cultures is shown in the right panel. *, p 0.01 (ANOVA with Scheffe post-hoc
tests) compared with PC12-VT. B, time course of MPP-induced CHOP mRNA and protein levels in cultures of PC12 cells transfected with siRNA-Herp or
siRNA-Con (100 nM). The cultures were incubatedwith 0.5mMMPP 24 h after transfection. Actin and ERK1were used as loading controls. Densitometric
analysis of protein bands normalized to untreated control cultures is shown in the right panel. *, p 0.01 (ANOVAwith Scheffe post-hoc tests) compared
with cultures transfectedwith siRNA-Con. C andD, PC12 cells were transfectedwith siRNA-CHOP or siRNA-Con (100 nM). One day after transfection, PC12
cells were exposed to 0.5 mM MPP or vehicle for the indicated time points and subsequently harvested for detection of Herp mRNA and protein (C) or
fixed for quantitation of cell death (D). Actin and ERK1 were used as loading controls. Densitometric analysis of protein bands normalized to untreated
control cultures is shown in the right panel. *, p  0.01 (ANOVA with Scheffe post-hoc tests) compared with cultures transfected with siRNA-Con. For
quantitation of cell death, the percentages of trypan blue-positive cells in each treated culture, normalized to vehicle-treated cultures, were shown. The
values are the means and S.D. of three dishes/group for each time point. *, p  0.01; #, p  0.05 (ANOVA with Scheffe post-hoc tests) compared with
cultures transfected with siRNA-Con.
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homeostasis (41). Dysregulation of
ER Ca2 homeostasis occurs as an
early event during many forms of
apoptosis and has been implicated
in the pathophysiology of several
acute and chronic neurodegenera-
tive diseases, including ischemic
injury, trauma, and Alzheimer,
Huntington, and prion diseases
(41–43). Uncontrolled Ca2 release
from the ER is a key proapoptotic
event, as indicated by the ability of
blockers of ER Ca2 release to
reduce the extent of ischemic injury
(44) and to protect culturedneurons
against cell death induced by gluta-
mate, mutant huntingtin, A, and
prion peptides (21, 45). Whether
dysregulation of ER Ca2 homeo-
FIGURE5.CHOP andHerpmodulates ER Ca2homeostasis inMPP-treated cells. Knockdown of CHOP
(A) and Herp (B) alters ER Ca2 store contents in MPP-treated PC12 cells. Twenty-four hours after co-
transfection with 2 g of pBudCE4.1-YC4-ER with the indicated siRNA duplexes (100 nM), cultures were
incubated with 0.5 mM MPP or vehicle control (Con). Changes in ER Ca2 concentration ([Ca2]ER) were
recorded at the indicated time points as described under “Experimental Procedures” and presented as
the ratios of the YC4-ER fluorescence signal in MPP-treated relative to untreated cultures. The values are
the means and S.D. of measurements made in three separate cultures (n  4 dishes, 4 –6 microscopic
fields/dish, 25–30 cells/field). *, p 0.01; #, p 0.05 (ANOVA with Scheffe post-hoc tests) compared with
cultures treated with siRNA-Con.
FIGURE 6. The ubiquitin-like (UBL) domain is essential for Herp-mediated stabilization of ER Ca2 homeostasis and rescue fromMPP toxicity.
A, schematic diagram of full-length Herp protein and a deletion mutant lacking the N-terminal UBL domain (UBL-Herp). Expression of Herp and
UBL-Herp protein in stably transfected PC12 clones is shown in the inset. ERK1 was used as the loading control. B, UBL-Herp fails to rescue PC12 cells
from MPP toxicity. The indicated PC12 clones were exposed to 0.5 mM MPP for the indicated time points. The results were expressed as percentage
of trypan blue-positive cells in each culture, normalized to vehicle-treated cultures, from three independent experiments. *, p 0.01; #, p 0.05 (ANOVA
with Scheffe post-hoc tests) compared with PC12-VT. C, UBL-Herp fails to stabilize ER Ca2 homeostasis. Twenty-four hours after transfection of
pBudCE4.1-YC4-ER, the indicated PC12 clones were incubated with 0.5 mM MPP. Changes in ER Ca2 concentration ([Ca2]ER) were recorded at the
indicated time points as described under “Experimental Procedures” and presented as the ratio of the fluorescence signals in MPP-treated relative to
untreated cultures. The values are the means and S.D. of measurements made in three or four cultures (n 4 dishes, 4 –6 microscopic fields/dish, 25–30
cells/field). *, p  0.01 (ANOVA with Scheffe post-hoc tests) compared with PC12-VT and PC12-UBL-Herp; #, p  0.05 (ANOVA with Scheffe post-hoc
tests) compared with PC12-VT. D, UBL-Herp fails to suppress MPP induced up-regulation of CHOP. Time course of MPP-induced increase in CHOP
protein level in the indicated stably transfected PC12 clones. As control for equal loading, immunoblots were reprobed with an antibody to ERK1.
Densitometric analysis of protein bands normalized to untreated control cultures is shown in the right panel. *, p 0.01 (ANOVA with Scheffe post-hoc
tests) compared with PC12-VT and PC12-UBL-Herp.
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stasis contributes to PD initiation and progression has not yet
been established.
Disturbances in intracellular Ca2 homeostasis could play a
role in dopaminergic degeneration because treatment with var-
ious PD neurotoxins has been shown to perturb intracellular
Ca2 homeostasis (26–28). The MPP-induced cell death was
inhibited by co-expression of calbindin-D28K or co-treatment
with BAPTA (1,2-bis-(o-aminophenoxy)-ethane-N,N,N,N-
tetracidic acid), suggesting a critical role for intracellular Ca2
loads in MPP-induced toxicity (46). The pertinent mecha-
nism whereby neurotoxins disrupt intracellular Ca2 homeo-
stasis remains poorly understood. Antagonists of glutamate
and Ca2 channels (47) have been reported ineffective in pre-
ventingMPP toxicity, suggesting that the Ca2 perturbations
induced by MPP are likely attributed to deregulated ER Ca2
release. Consistent with the latter notion, inhibition of ERCa2
release prevents the MPP-induced perturbations of intracel-
lular Ca2 (47).
Various pathological conditions that induce ER stress have
been shown to perturb ERCa2 homeostasis (8, 16, 29), but the
underlying mechanisms remain poorly characterized. Oxida-
tive damage to the ER can lead to perturbations in ER Ca2
homeostasis. Protein folding in the
ER can generate ROS, which in turn
may exacerbate ER stress by per-
turbing the function of ER foldases
and/or chaperones (48). ROS could
also sensitize ryanodine receptor-
and inositol triphosphate receptor-
mediated ER Ca2 release (49, 50)
or block sarcoplasmic/endoplasmic
reticulum Ca2-ATPase-mediated
Ca2 sequestration by the ER (51).
During ER stress, increased Ca2
transfer from the ER to mitochon-
dria leads to mitochondria Ca2
overload and generation of mito-
chondrial-derived ROS, which
could further disrupt protein fold-
ing in the ER and potentiate ER
Ca2 release through a positive
feed-forward mechanism (52, 53).
Recent studies show that neuro-
toxins induce ER stress via the
generation of ROS (54, 55), sug-
gesting that ER stress may be
involved downstream of ROS. The
biological relevance of the neuro-
toxin induced-ER stress is still
unknown. Given that ER is an
important regulator of intracellu-
lar Ca2 homeostasis, oxidant-in-
duced deregulation of ER Ca2
homeostasis could contribute to
dopaminergic degeneration.
Induction of ER stress proteins
during oxidative and ER stress
seems to be important to remedy
the perturbations of ER Ca2 homeostasis. We previously
reported thatHerp is essential for cell survival in response to ER
stress (16).Here, we found thatHerp is critical for cellular stress
adaptation in response to MPP. Consistent with this notion,
we found that overexpression of Herp attenuated MPP-in-
duced toxicity, whereas knockdown of Herp increased not only
CHOP expression but also ER Ca2 leakage and mitochondrial
Ca2 accumulation, resulting in cell death (Fig. 1). Notably, we
found that MPP failed to up-regulate Herp expression in do-
paminergic cells in vitro (Fig. 2, A and B). Failure to induce a
compensatory increase in Herp expression may deteriorate ER
function in MPP-treated cells. Hence, exploring ways to
increase Herp expression can increase the ability of dopamin-
ergic cells to cope with ER stress and to protect from MPP
toxicity.
Given that Herp plays a crucial role in stabilizing ER Ca2
homeostasis (16, 17), we determined whether stable expression
ofHerp counteractsMPP-induced toxicity by inhibiting Ca2
transfer from ER to mitochondria. Time course analysis of the
MPP-induced alterations in [Ca2]ER and [Ca2]M revealed
that knockdown of Herp accelerates ER Ca2 store depletion
with a time course that parallels [Ca2]M accumulation (Fig.
FIGURE 7. Proteasomal-mediated degradation is essential for Herp-dependent stabilization of ER Ca2
homeostasis and rescue fromMPP toxicity. A, the proteasomal inhibitor lactacystin abolishes Herp-medi-
ated suppression of CHOP in MPP-treated PC12 cells. Time course of CHOP and Grp78 protein levels in
PC12-Herp cultures incubatedwith 0.5mMMPP in thepresenceor absenceof lactacystin (5M). As control for
equal loading, immunoblots were reprobed with an antibody to ERK1. B, lactacystin abolishes the Herp-de-
pendent suppression of ER Ca2 store depletion inMPP-treated PC12 cells. Twenty-four hours after transfec-
tion with 2 g of pBudCE4.1-YC4-ER, the cultures of PC12-Herp were incubated with 0.5 mM MPP in the
presenceof lactacystin (5M) or its vehicle control. Changes in ERCa2 concentration ([Ca2]ER)were recorded
at the indicated time points as described under “Experimental Procedures” and presented as the ratio of the
YC4-ER fluorescence signal inMPP-treated relative tountreated cultures. The values are themeans andS.D. of
measurements made in three or four cultures (n 4 dishes, 4–6 microscopic fields/dish, 25–30 cells/field). *,
p 0.01 (ANOVAwith Scheffe post-hoc tests).C andD, lactacystin enhancesMPP toxicity (C) and reverses the
Herp-dependent cell death rescue fromMPP toxicity (D). Cultures of PC12 (C) and PC12-Herp clones (D) were
exposed to 0.5 mMMPP in the presence of lactacystin (5 M) or vehicle control for the indicated time points.
Shown is the percentage of trypan blue-positive cells in each culture, normalized to untreated cultures, from
three independent experiments. *, p  0.01 (ANOVA with Scheffe post-hoc tests) compared with vehicle-
treated cultures.
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3B) and that overexpression of Herp reversed the toxic Ca2
transfer between the ER and mitochondria (Fig. 3, A and B).
The mitochondrial apoptotic pathway is an integral part of
MPP-induced apoptosis (24, 25). Excessive accumulation of
[Ca2]M causes collapse of themitochondriamembrane poten-
tial, which results inmitochondrial transition pore opening and
release of pro-apoptogenic factors including cytochrome c that
promotes downstream caspase activation (53). Because mito-
chondria are linked to the ER both by proximity and through
Ca2 signaling (52, 56), various pathological conditions that
perturb ER Ca2 homeostasis could adversely impact the func-
tion of the mitochondria. Hence, oxidant-induced damage to
the ER could cause a protracted elevation in [Ca2]M that could
enhance generation of mitochondrial-derived ROS that
through a feed forwardmechanism exacerbates the loss of Ca2
from the ER (53).
The underlyingmolecular and cellular mechanisms whereby
Herp stabilizes ER Ca2 homeostasis and preserves mitochon-
drial function inMPP-treated cells remain to be established. It
is unlikely that the ERmembrane-associated Herp functions as
a calcium-binding chaperone analogous to Grp78 and calreti-
culin (14). We excluded a role for Bcl-2 in the Herp-mediated
stabilization of ERCa2 homeostasis based on the findings that
Herp fails to bind to Bcl-2 and that total levels of Bcl-2 in the
microsome fractions were not significantly different in
PC12-VT and PC12-Herp cells (supplemental Fig. S4). Hence,
themechanism bywhichHerpmaintains ERCa2 homeostasis
appears to be different from the proposed anti-apoptotic action
of Bcl-2 (37). Because the UBL domain is essential for Herp-
mediated protection against neurotoxins (Fig. 7B), we deter-
mined that theUBLdomain is essential for the ability ofHerp to
maintain ER Ca2 homeostasis. Expression of Herp lacking the
UBL domain fails to stabilize intracellular Ca2 and to suppress
the induction of CHOP inMPP-treated cells (Fig. 7,C andD),
indicating that UBL is critical for the cytoprotective function of
Herp.
How the UBL domain is involved in the protective function
of Herp is not clear. The presence of the UBL domain, which
faces into the cytosol (14), suggests that Herpmay function as a
proteasome-interacting domain, as has recently been demon-
strated for Parkin (57). Several recent studies support a role of
Herp in ERAD (38, 39). Herp interacts with Hrd1p, a mem-
brane-anchoredE3 ligase (38), andwith ubiquilin, a shuttle pro-
tein that delivers ubiquitinated substrates to the proteasome for
degradation (58). Overexpression of Herp enhances the degra-
dation of the ERAD substrate CD3, whereas siRNA-mediated
reduction of Herp expression stabilized the ERAD substrate
CD3 but did not alter or increased degradation of non-ERAD
substrates tested (38). It is possible that Herp may target yet to
be identified CHOP-regulated ERAD substrates whose accu-
mulation results in perturbations in ER Ca2 homeostasis.
Hence, elucidating the precise role of Herp in ERAD and the
identity of the ERAD substrates that accumulate in Herp
knockdown cells will likely provide clues to the mechanisms of
Herp-mediated ER Ca2 stabilization and protection from
MPP-induced toxicity.
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